OC-0309: Role of age, grade and RT dose on outcome of 177 ependymoma - 13 years experience of Child's cancer French Society  by Ducassou, A. et al.
3rd ESTRO Forum 2015                                                                                                                                         S155 
 
F. Tensaouti1, A. Ducassou2, S. Liceaga1, J.A. Lotterie3, A. 
Sevely4, P. Peran1, I. Berry4, S. Ken2, P. Celsis1, A. Laprie2 
1INSERM, UMR 825, Toulouse, France 
2Institut du Cancer de Toulouse, Radiotherapy, Toulouse, 
France  
3CHU Toulouse, Radiotherapy, Toulouse, France  
4CHU Toulouse, Radiology, Toulouse, France  
 
Purpose/Objective: Ependymoma is the third most common 
primary brain tumor in children. Radiotherapy is 
systematically delivered after surgery. However, more than a 
third of children experience relapse locally or around the 
resection cavity wall.  
One important factor influencing clinical outcome after 
radiotherapy is the reduced oxygen levels (hypoxia). Major 
noninvasive technique suggested as capable of monitoring 
tumour hypoxia involves MR, and includes both perfusion MRI 
(by dynamic contrast-enhanced MRI, DCE) and diffusion-
weighted imaging (DWI).  
The aim of this study was to investigate if DCE or DWI MRI can 
predict radiotherapy outcome in pediatric ependymoma by 
identification of significant hypoxic subvolumes of tumors 
related to treatment outcomes and that resistance resulting 
from this hypoxia can be overcome by increasing radiation 
dose. 
Materials and Methods: 197 patients were included in this 
national retrospective study, performed in 11 french 
reference centers for pediatric radiation oncology. All 
patients underwent surgical resection and postoperative 
radiochimiotherapy. Imaging data from 93 patients could be 
retrieved. Among them eleven patients had DCE MRI and 
fifteen had DWI MRI at pre radiotherapy exam. All image 
analyses were completed using an in-house software package: 
Sisyphe. For each patient, the resection cavity was 
delineated on the post contrast T1WI. The resulting Region of 
interest (ROI) was mapped to the coregistered CBV and ADC 
map. An histogram analysis was done to determine for both 
CBV and ADC the best fitting of the data hitogramm with 2 or 
3 Gaussian functions. According to the fitting results, the 
cavity ROI was then partitioned into 2 or 3 spatial subvolumes 
using an automatic clustering method (Isodata algorithm). 
Each subvolume with the lower CBV or lower ADC was 
normalized to the ROI volume and evaluated for its 
association with outcome. 
Results: The percentage of the subvolumes with low ADC, 
was not signi?cantly different between the patients with 
Local Failure (LF) and local control (LC) (p = 0.9). The 
percentage of the subvolumes with low CBV, were 
signi?cantly greater, in the patients with LF than with LC ( p 
= 0.025). The ROC analysis indicates that for a subvolume of 
69 % of the volume ROI with low CBV had greater speci?city 
for prediction of local failure (specificity =80%, 
sensibility=100%). 
Conclusions: In our study perfusion MRI was a predictive 
factor of radiotherapy outcome in pediatric ependymoma. 
This is a promising finding as radio resistance resulting from 
hypoperfusion and consequent hypoxia could be overcome by 
increasing radiation dose to the poorly perfused defined 
subvolumes. Confirmation of our imaging data is in progress 
with completion of our database that will allow to present 
our final results to the meeting.  
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Purpose/Objective: to investigate the influence on Event 
free survival ( EFS) and overall survival ( OS ) of main 
characteristics of patients, disease and treatments for 
pediatric patients with localised ependymoma in a national 
cohort 
Materials and Methods: A total of 177 patients with newly 
diagnosed intracranial ependymoma were treated with 
adjuvant Radiation therapy (RT) in the 11 French major 
radiation oncology centers between January 2000 and 
December 2013.  
Clinical data were retrospectively gathered on a web-based 
national database between March and October 2014. 
Results: Location was posterior fossa in 77%, supratentorial 
in 23 %. Anaplastic features were present in 56% of patients. 
The extent of resection was characterized as gross-total in 
86% patients and subtotal in 14%. The median dose to the 
primary site was 59.4 Gy, 37% of patients received a dose ≤54 
Gy. Fifty-one patients received pre-RT chemotherapy. RT was 
3D conformal in 107 patients, IMRT in 60 (of which 18 
tomotherapy) and protontherapy in 10. 
With a median follow up time of 43.1 months from the start 
of RT (95%CI (33,5-52.6)), the 3-years local relapse-free 
survival (LRFS) was 67,8%. Recurrences after RT occurred in 
73 patients (41%) and were mainly local (strictly local in 62% 
of recurrences, local and distant in 7% and strictly distant in 
25%). 
The RT dose significantly influenced overall survival (OS) and 
event-free survival (EFS) after RT. The estimated 3-year OS 
and EFS rates were respectively 90 % and 67% for patients 
who received a dose > 54Gy compared with 79% and 52% for 
patients who received a dose ≤54 Gy (respectively p= 0.008 
and p=0.02). OS and EFS at 3 years were significantly 
improved for patients older than 3 years of age at the 
initiation of RT (92 and 68%) compared to children younger 
than 3 years (71 and 43%) (p=0.0007 and p=0.0001). EFS at 3 
years was greater in grade 1-2 (74%) than in grade 3-4 (53%) 
(p=0.004), OS was also greater in grade 1-2 (97%) than grade 
3-4 (81%) but this was not statistically significant.  
There was no significant difference in OS or EFS regarding the 
quality of surgery, the use of chemotherapy or the technique 
of radiotherapy.  
Conclusions: This large multicentric French cohort confirms 
that a dose > 54 Gy improved survival in localised cerebral 
ependymoma. Age younger than 3 years at initiation of RT 
and grade 3-4 were significant prognostic factors of worse 
outcome. 
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